The impact of gut bacteria on immune suppressants used in kidney transplants
Gut Microbiota and Effect on Immune Suppressants in Transplantation
This study is looking at how the bacteria in your gut might change how well certain medications work for kidney transplant patients, helping to find better ways to tailor treatments just for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11224812 on NIH RePORTER |
What this research studies
This research investigates how gut microbiota affects the pharmacokinetics of immune suppressants, specifically mycophenolate mofetil (MMF) and tacrolimus, in kidney transplant patients. It aims to understand the relationship between gut bacteria and the effectiveness and toxicity of these medications, which are crucial for preventing organ rejection. By analyzing stool samples and measuring drug levels, the study seeks to identify specific bacterial patterns that may influence drug metabolism and patient outcomes. This could lead to personalized treatment strategies based on individual microbiome profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have undergone kidney transplantation and are currently receiving immune suppressants like MMF or tacrolimus.
Not a fit: Patients who have not undergone kidney transplantation or are not taking immune suppressants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dosing strategies for immune suppressants, reducing the risk of organ rejection and minimizing side effects for kidney transplant patients.
How similar studies have performed: Previous studies have shown promising results in understanding the role of gut microbiota in drug metabolism, suggesting that this approach could yield valuable insights.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Israni, Ajay K — University of Texas Med Br Galveston
- Study coordinator: Israni, Ajay K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.